New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 20, 2012
19:16 EDTMU, RHT, RIMM, TIBX, HEB, WWAY, NKEOn The Fly: After Hours Movers
UP AFTER EARNINGS: Nike (NKE), up 5%... Tibco Software (TIBX), up 4.7%... Red Hat (RHT), up 5.6%... ALSO HIGHER: Westway Group (WWAY), up 8% after an affiliate of EQT Infrastructure agreed to acquire the company for $6.70 per share... DOWN AFTER EARNINGS: Research in Motion (RIMM), down 10%... Micron Technology (MU), down 3.2%... ALSO LOWER: Hemispherx BioPharma (HEB), down 24% after Bloomberg reported that an FDA advisory panel voted against recommending approval for the company's drug Ampligen.
News For NKE;TIBX;RHT;WWAY;RIMM;MU;HEB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
November 20, 2014
16:18 EDTNKENike raises quarterly dividend to 28c per share from 24c per share
Subscribe for More Information
16:17 EDTRHTRed Hat initiated with a Hold at Jefferies
Subscribe for More Information
12:47 EDTNKENike opens first women only store in CA, Bloomberg reports
Subscribe for More Information
November 19, 2014
10:29 EDTMUGoogle now top competitor to Apple, Jefferies says
Subscribe for More Information
November 18, 2014
08:54 EDTNKENike initiated with a Hold at BB&T
Subscribe for More Information
08:54 EDTNKENike initiated with a Hold at BB&T
08:13 EDTMUMicron announces CFO Foster to retire in 2015
Subscribe for More Information
07:31 EDTNKESignet Jewelers names Daniel Shull as Chief Information Officer
Subscribe for More Information
05:58 EDTMUMicron implied volatility of 32 at lower end of index mean range
Subscribe for More Information
November 17, 2014
09:36 EDTMUActive equity options trading
Active equity options trading according to Track Data: AAPL PBR BHI GILD MU HD AMZN TSLA YHOO FB TWTR
09:27 EDTHEBHemispherx says Ampligen blocks certain Ebola Viral Disease protein
Hemispherx Biopharma announced that it had received a new research report from Professor Tramontano in the Department of Life and Environmental Sciences, University of Cagliari, Italy. The biochemical study demonstrates Ampligen can successfully bind to the lethal EVD viral protein designated VP35. Experiments being conducted establish the scientific foundation for Ampligen, an experimental drug, as a potential preventive and early onset therapeutic for Ebola, the company said.
06:08 EDTMUMicron implied volatility of 33 at lower end of index mean range
November 14, 2014
16:52 EDTMUGreenlight Capital gives quarterly update on stakes
Subscribe for More Information
10:00 EDTNKEOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
06:31 EDTNKENike downgraded to Neutral from Buy at Sterne Agee
Sterne Agee downgraded Nike to Neutral based on valuation.
November 13, 2014
07:57 EDTNKENike positioned to 'significantly increase' dividend, says Nomura
Subscribe for More Information
November 12, 2014
05:51 EDTMUMicron checks show stonger than expected DDR4 demand, says Piper Jaffray
Subscribe for More Information
November 10, 2014
15:16 EDTMUMicron to increase Japan investment to up DRAM output, Nikkei says
Subscribe for More Information
08:48 EDTHEBHemispherx reports Q3 EPS (2c), one estimate (3c)
Subscribe for More Information
06:17 EDTNKENike price target raised to $107 from $93 at Citigroup
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use